Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01454791 · ClinicalTrials.gov registry record · Phase 4
Diclofenac Sodium Topical Gel to Reduce Injection Site Discomfort in Patients Taking Glatiramer Acetate
A Phase 4 study, sponsored by Brown, Theodore R., M.D., MPH.
- Completed
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
NCT01454791 is a Phase 4 study that has completed, run by Brown, Theodore R., M.D., MPH. The registered enrollment target is 40 participants.
The verdict
NCT01454791, a Phase 4 study, has completed, sponsored by Brown, Theodore R., M.D., MPH.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the effect of Diclofenac Sodium Topical Gel (DSTG) on injection site reaction following self-administer glatiramer acetate in people with Multiple Sclerosis.
Interventions
- OTHER Placebo
- DRUG diclofenac sodium topical gel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2011-01 |
| Est. Completion | 2013-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01454791
The ClinicalTrials.gov registry entry for NCT01454791 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brown, Theodore R., M.D., MPH, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01454791 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01454791 about?
NCT01454791 is a clinical study titled "Diclofenac Sodium Topical Gel to Reduce Injection Site Discomfort in Patients Taking Glatiramer Acetate". The purpose of this study is to assess the effect of Diclofenac Sodium Topical Gel (DSTG) on injection site reaction following self-administer glatiramer acetate in people with Multiple Sclerosis.
What is the current status of trial NCT01454791?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2011-01. Estimated completion is 2013-03.
What interventions are being tested in trial NCT01454791?
The interventions under investigation include: Placebo (OTHER), diclofenac sodium topical gel (DRUG).
Who is sponsoring clinical trial NCT01454791?
This trial is sponsored by Brown, Theodore R., M.D., MPH, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.